• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Emergency Preparedness and Response

  • Print
  • Share
  • E-mail

MCMi Regulatory Science Symposium


2014 MCMi Regulatory Science Symposium Save the DateFDA’s Medical Countermeasures initiative (MCMi) sponsors an annual Regulatory Science Symposium to exchange ideas on MCM development; highlight work on regulatory science as it applies to developing and advancing MCMs; facilitating innovative directions; and informing stakeholders on MCM-related scientific progress and achievements.




2014 MCMi Regulatory Science Symposium

4.3 A rapid, multiplexed, mobile phone-enabled point of care diagnostic device to detect Category A bioterror agents. Tam, J.; Yen, C.,; de Puig Guixe, H.; Miyazaki, H.; Fiegen, A.; Phillips, E.; Gomez-Marquez, J.; Hamad-Schifferli, K.; Bosch, I., Regan, P.; Clavet, C.; and Gehrke, L. FDA, Massachusetts Institute of Technology and Harvard Medical School.

Honorable mention: 5.1 Imaging Enterobacteriaceae Infection with Fluorodeoxysorbitol Positron Emission Tomography. Weinstein, E.; Ordonez, A.; DeMarco, V.; Murawski, A.; Pokkali, S.; MacDonald, E.; Klunk, M.; Mease, R.; Pomper, M.; and Jain, S. FDA CDER.

Honorable mention: 2.6  Development and Validation of Electroencephalographic (EEG) Biomarkers for Brain Injury Monitoring. Ye, M.; Fisher, J.; Nabili, M.; Huang, S.; Kim, Y.; Liu, Y.; Krauthamer, V.; Civillico, E.; Myers, M.; and Welle, C. FDA CDRH


2013 MCMi Regulatory Science Symposium


 2012 MCMi Regulatory Science Symposium